MMP9 and Alzheimer disease: Indeed, by examining the gene expression profile of whole brains and of purified microglia, we found that partial microglial CX3CR1 deficiency reverses or slows the reduction in insulysin and MMP9 Aβ-degrading enzymes observed in PS1-APP mice as they age, and their AD-like pathology progresses.